Recently, in a large-scale computational study on previous tumor datasets reporting markers of T cell exhaustion, TLT-1 (TREML1) was among the top upregulated markers associated with T cell dysfunction (Jiang et al., 2018); however, its role in antitumor immunity has not yet been explored. The gene discussed is TREML1; the disease is neoplasm.